دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Acceptability of Vaccines Against Preventable Infections Including Coronavirus Disease 2019 Among Patients With Rheumatic Disease
Sara K. Tedeschi MD, MPH,Jack Ellrodt AB,Jacklyn Stratton BS,Leah Santacroce MS,Paulette D. Chandler MD, MPH,Ellen M. Gravallese MD,Daniel H. Solomon MD, MPH
doi : 10.1002/acr2.11351
Volume 4, Issue 1 p. 3-7
Vaccination against preventable infections is widely recommended for patients with systemic rheumatic disease. The coronavirus disease 2019 (COVID-19) pandemic has highlighted variability in attitudes toward vaccination, particularly with the use of novel vaccine platforms. We studied attitudes toward vaccination against COVID-19 and other preventable infections among patients with systemic rheumatic disease and compared these against the general population.
Validation of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis as the Cause of End-Stage Renal Disease in the US Renal Data System
Claire E. Cook,Xiaoqing Fu,Yuqing Zhang,John H. Stone,Hyon K. Choi,Zachary S. Wallace
doi : 10.1002/acr2.11359
Volume 4, Issue 1 p. 8-12
The objective of this study was to validate the diagnosis of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) as the primary cause of end-stage renal disease (ESRD) in the US Renal Data System (USRDS).
Vascular Ultrasound for Giant Cell Arteritis: Establishing a Protocol Using Vascular Sonographers in a Fast-Track Clinic in the United States
Charles Oshinsky MD,Alison M. Bays MD, MPH&TM,Ingeborg Sacksen MD,Elizabeth Jernberg MD,R. Eugene Zierler MD, RPVI,Andreas P. Diamantopoulos MD, PhD,Jean W. Liew MD, MS,Sarah H. Chung MD,P. Scott Pollock MD
doi : 10.1002/acr2.11346
Volume 4, Issue 1 p. 13-18
We developed a fast-track clinic (FTC) to expedite the evaluation of patients suspected of having giant cell arteritis (GCA) using vascular ultrasound. Though FTCs have demonstrated efficacy in Europe, no protocolized clinic in the United States has been developed. This study introduces a new FTC model unique to the United States, using vascular sonographers, and describes the protocols used to develop reliable findings. We evaluate clinical outcomes using vascular ultrasound and temporal artery biopsy (TAB).
Determinants of Tumor Necrosis Factor Inhibitor Use in Juvenile Spondyloarthropathy and Impact on Clinical Disease Outcomes
Melissa Oliver,Julia F. Simard,Tzielan Lee,Dana Gerstbacher,Christy Sandborg
doi : 10.1002/acr2.11353
Volume 4, Issue 1 p. 19-26
The objectives of this study were to characterize the reasons for tumor necrosis factor inhibitor (TNFi) initiation in patients with juvenile spondyloarthropathy (JSpA) and identify clinical correlates and to assess the effect of TNFi therapy on JSpA disease activity.
Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations
Lina-Marcela Diaz-Gallo PhD,Vilija Oke MD, PhD,Emeli Lundström PhD,Kerstin Elvin MD, PhD,Yee Ling Wu PhD,Susanna Eketjäll PhD,Agneta Zickert MD, PhD,Johanna T. Gustafsson MD, PhD,Andreas Jönsen MD, PhD,Dag Leonard MD, PhD,Daniel J. Birmingham MD, PhD,Gunnel Nordmark MD, PhD,Anders A. Bengtsson MD, PhD,Lars Rönnblom MD, PhD,Iva Gunnarsson MD, PhD,Chack-Yung Yu DPhil,Leonid Padyukov MD, PhD,Elisabet Svenungsson MD, PhD
doi : 10.1002/acr2.11343
Volume 4, Issue 1 p. 27-39
The heterogeneity of systemic lupus erythematosus (SLE) constitutes clinical and therapeutical challenges. We therefore studied whether unrecognized disease subgroups can be identified by using autoantibody profiling together with HLA-DRB1 alleles and immunological and clinical data.
Networks of Care: A Social Network Perspective of Distributed Multidisciplinary Care for People With Inflammatory Arthritis
Wendy Hartford,Catherine L. Backman,Linda C. Li,Shanon McQuitty,Annette McKinnon,Raheem Kherani,Laura Nimmon
doi : 10.1002/acr2.11349
Volume 4, Issue 1 p. 40-56
To explore how multidisciplinary inflammatory arthritis (IA) care is accessed from the perspectives of people with IA and their health care network members.
A Bridge Too Far? Real-World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort
Kathleen M. Andersen MSc,Orit Schieir PhD,Marie-France Valois MSc,Susan J. Bartlett PhD,Louis Bessette MD, MSc,Gilles Boire MD, MSc,Boulos Haraoui MD,Glen Hazlewood MD, PhD,Carol Hitchon MD, MSc,Edward C. Keystone MD,Janet Pope MD, MPH,Diane Tin,J Carter Throne MD,Vivian P. Bykerk MD, on behalf of CATCH Investigators
doi : 10.1002/acr2.11334
Volume 4, Issue 1 p. 57-64
To describe patterns of glucocorticoid use in a large real-world cohort with early rheumatoid arthritis (RA) and assess the impact on disease activity and treatment.
TNFi Cycling Versus Changing Mechanism of Action in TNFi-Experienced Patients: Result of the Corrona CERTAIN Comparative Effectiveness Study
Jeffrey R. Curtis MD, MS, MPH,Joel M. Kremer MD,George Reed PhD,Ani K. John PhD, MPH, BSN,Dimitrios A. Pappas MD, MPH
doi : 10.1002/acr2.11337
Volume 4, Issue 1 p. 65-73
Comparative effectiveness research can inform treatment decisions regarding the choice of biologics for rheumatoid arthritis (RA). The objective of this study is to compare the efficacy of tumor necrosis factor inhibitors (TNFis) and non-TNFis (nTNFis) in real-world patients with RA and past TNFi experience.
Feasibility of T2 Mapping of the Sacroiliac Joints in Healthy Control Subjects and Children and Young Adults with Sacroiliitis
Michael L. Francavilla,Suraj D. Serai,Timothy G. Brandon,David M. Biko,Dmitry Khrichenko,Jie C. Nguyen,Rui Xiao,Nancy A. Chauvin,Liya Gendler,Pamela F. Weiss
doi : 10.1002/acr2.11354
Volume 4, Issue 1 p. 74-82
To assess the feasibility of T2 mapping for evaluating pediatric SIJ cartilage at 3 Tesla (T) magnetic resonance imaging (MRI).
Patients with checkpoint inhibitor-induced inflammatory arthritis do not become seropositive for anti-cyclic citrullinated peptide when followed over time
Laura C. Cappelli,Erika Darrah,Ami A. Shah,Clifton O. Bingham
doi : 10.1002/acr2.11363
Volume 4, Issue 1 p. 83-84
Treatment Satisfaction and Decision-making from the Patient Perspective in Axial Spondyloarthritis: Real-World Data from a Descriptive Cross-sectional Survey Study from the ArthritisPower Registry
William Benjamin Nowell,Kelly Gavigan,Theresa Hunter,William N. Malatestinic,Rebecca J. Bolce,Jeffrey R. Lisse,Carol Himelein,Jeffrey R. Curtis,Jessica A. Walsh
doi : 10.1002/acr2.11365
Volume 4, Issue 1 p. 85-94
Aims were to 1) to characterize patient decision-making with treatment for axial spondyloarthritis (axSpA) and 2) to explore relationships among decision-making, treatment satisfaction, and biologic disease modifying antirheumatic drugs (bDMARDs).
Clinical Image: Phytophotodermatitis: A butterfly-like rash on the face of a young woman
Yanyan He,Wenzhu Wang,Deguo Xu,Haoxiang Xu
doi : 10.1002/acr2.11369
Volume 4, Issue 1 p. 95-95
